Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 8,542 | 8,576 | 7,902 | 8,735 | 8,395 |
| Cost of Goods | 7,126 | 7,008 | 6,794 | 7,271 | 6,747 |
| Gross Profit | 1,416 | 1,567 | 1,107 | 1,464 | 1,648 |
| Operating Expenses | 530 | 509 | 577 | 602 | 565 |
| Operating Income | 885 | 1,058 | 530 | 862 | 1,083 |
| Other Income | 499 | -71 | 807 | -54 | 103 |
| Pre-tax Income | 1,385 | 987 | 1,338 | 809 | 1,186 |
| Income Tax | 313 | 203 | 368 | 322 | 497 |
| Net Income Continuous | 1,072 | 784 | 970 | 486 | 689 |
| Net Income | $1,072 | $784 | $970 | $486 | $689 |
| EPS Basic Total Ops | 0.06 | 0.04 | 0.05 | 0.04 | 0.06 |
| EPS Basic Continuous Ops | 0.06 | 0.04 | 0.05 | 0.04 | 0.06 |
| EPS Diluted Total Ops | 0.06 | 0.04 | 0.05 | 0.04 | 0.06 |
| EPS Diluted Continuous Ops | 0.06 | 0.04 | 0.05 | 0.04 | 0.06 |
| EBITDA(a) | $1,416 | $1,567 | $1,107 | $1,487 | $1,648 |